Efficacy and tolerability of a one‐week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer
- 1 February 1997
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 11 (1) , 95-100
- https://doi.org/10.1046/j.1365-2036.1997.130301000.x
Abstract
Background: Previous studies have shown that one-week triple therapy consisting of omeprazole, clarithromycin and amoxycillin may cure Helicobacter pylori infection in the vast majority of patients. The present study was designed to test the hypothesis that a triple therapy with pantoprazole, clarithromycin and amoxycillin cures the infection in 80% of duodenal ulcer patients infected with H. pylori. Methods: In an open two-centre study, 60 duodenal ulcer patients were treated with pantoprazole 40 mg b.d., clarithromycin 500 mg b.d. and amoxycillin 1 g b.d. for 1 week. During the second week patients received pantoprazole 40 mg once in the morning. We assessed H. pylori infection before treatment and 4 weeks after cessation of the study medication by a rapid urease test, histology after Warthin–Starry stain and a 13C-urea breath test. Results: Sixty patients (42 males, mean age 47.4 years) entered the trial. All patients were infected with H. pylori. One patient was withdrawn from the study because of allergy to penicillin and six patients were protocol violators. H. pylori infection was cured in 47 out of 53 patients who completed the trial according to the protocol (89%; 95% CI: 80–97%) and in 49 of 60 patients included in the trial (82%; 95% CI: 72–92%). Four weeks after the last administration of study drugs, 55 out of 60 ulcers had healed (92%). Twenty-nine patients reported 51 adverse events that were mostly mild to moderate. Conclusions: One-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin is a simple and effective approach to the cure of H. pylori infection in patients with duodenal ulcer. In those patients who took the drugs as prescribed the H. pylori cure rate was 89%, with the lower 95% confidence limit being 80%.Keywords
This publication has 20 references indexed in Scilit:
- PantoprazoleDrugs, 1996
- One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1996
- Eradication of Helicobacter pylori using clarithromycin, omeprazole and amoxycillin for one week: KA Tonge, AF Goddard∗, ∗, PA Gummett, CJ Hawkey∗, JJ Misiewicz, JH Baron. Parkside Helicobacter Study Group, London & Div of Gastroenterology∗, University Hospital, Nottingham UKGastroenterology, 1995
- Omeprazole plus one or two antibiotics to eradicate H. pylori: M. Buckley, S. Keating, H. Xia, S. Beattie, H. Hamilton, C O'Morain. Dept. of Gastro., Meath/Adelaide Hospitals, Dublin, IrelandGastroenterology, 1995
- Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer diseaseGastrointestinal Endoscopy, 1995
- Peptic ulcer pathogenesisCurrent Opinion in Gastroenterology, 1995
- Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pyloriJournal of Antimicrobial Chemotherapy, 1994
- The Role of Acid Inhibition in the Treatment ofHelicobacter pyloriInfectionScandinavian Journal of Gastroenterology, 1994
- Role of Helicobacter pylori Eradication in the Prevention of Peptic Ulcer Bleeding RelapseDigestion, 1994
- Antibacterial activity of pantoprazole and omeprazole againstHelicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991